stars 1 stars 2 stars 3

Founded in the Netherlands in 1995, for more than two decades MariPharm® has undertaken pioneering work and research into Medical Grade Cannabis®, advising governments on how to establish and manage medicinal cannabis programs aimed at improving the quality of life and health of its citizens. Years of research supported by leading scientists, universities, government agencies, research institutes, pharmacists and doctors, backed by an Opium License from the Dutch Ministry of Health, Sports and Welfare, have resulted in high-quality and safe (CBD-) products. CBD products MariPharm® has consistently utilized innovative technologies, and has developed a revolutionary extraction process for CBD that consistently guarantees the highest quality pharmaceutical-grade product, formulated from pure CBD extract produced according to the most stringent EU GMP standards. Quality Control MariPharm® maintains a dedicated, high-tech laboratory for quality control, with third-party quality oversight and testing guaranteed by renowned Dutch Government approved laboratory that issues Certificates of Analysis for each batch of CBD oil.

MariPharm® Questions

Marcel de Wit is the CEO of MariPharm®.

6 people are employed at MariPharm®.

Top MariPharm® Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users